Patents by Inventor Penco Sergio

Penco Sergio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7273873
    Abstract: Compounds of formula (I) or (II) are described: where the groups are as defined in the description here below, the racemic mixtures, their individual enantiomers, their individual diastereoisomers, their mixtures, and their pharmaceutically acceptable salts. Said compounds are topoisomerase I inhibitors.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: September 25, 2007
    Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Instituto Nazionale per Lo Studio e La Cura Dei Tumori
    Inventors: Mauro Marzi, Elena Marastoni, Claudio Pisano, Maria Ornella Tinti, Cabri Walter, Alpegiani Marco, Vergani Domenico, Danelli Tamara, Gomez Patricio Martin, Vesci Loredana, Zunino Franco, Penco Sergio
  • Publication number: 20050154003
    Abstract: Compounds of formula (I) or (II) are described: where the groups are as defined in the description here below, the racemic mixtures, their individual enantiomers, their individual diastereoisomers, their mixtures, and their pharmaceutically acceptable salts. Said compounds are topoisomerase I inhibitors.
    Type: Application
    Filed: May 28, 2003
    Publication date: July 14, 2005
    Inventors: Mauro Marzi, Elena Marastoni, Claudio Pisano, Maria Ornella Tinti, Cabri Walter, Alpegiani Marco, Vergani Domenico, Danelli Tamara, Gomez Patricio Martin, Vesci Loredana, Zunino Franco, Penco Sergio
  • Publication number: 20050107331
    Abstract: Partially desulphated glycosaminoglycan derivatives are described, particularly heparin, and more particularly formula (I) compounds, where the U, R and R1 groups have the meanings indicated in the description. The glycosaminoglycan derivatives are endowed with antiangiogenic activity and are devoid of anticoagulant activity.
    Type: Application
    Filed: October 19, 2004
    Publication date: May 19, 2005
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Casu Banito, Torri Giangiacomo, Naggi Anna Maria, Giaonini Ginseppe, Pisano Claudio, Penco Sergio
  • Publication number: 20040235757
    Abstract: Are described compounds of Formula (I) in which R, R′, R″, A, and D have the meanings described in the text, as useful agents in the cure of pathologies characterised by altered angiogenesis and as antitumorals.
    Type: Application
    Filed: February 2, 2004
    Publication date: November 25, 2004
    Inventors: Dallavalle Sabrina, Merlini Lucio, Pisano Claudio, Vesci Loredana, Giannini Giuseppe, Penco Sergio
  • Publication number: 20030149068
    Abstract: A series of compounds of natural origin are described, as useful agents for the treatment of diseases characterised by abnormal angiogenesis. These compounds are: chrysanthone A having formula (I); chrysanthone B having formula (II); and chrysanthone C having formula (III).
    Type: Application
    Filed: November 6, 2002
    Publication date: August 7, 2003
    Inventor: Penco Sergio
  • Publication number: 20030013682
    Abstract: Partially desulphated glycosaminoglycan derivatives are described, particularly heparin, and more particularly formula (I) compounds, where the U, R and R1 groups have the meanings indicated in the description. Said glycosaminoglycan derivatives are endowed with antiangiogenic activity and are devoid of anticoagulant activity.
    Type: Application
    Filed: July 25, 2002
    Publication date: January 16, 2003
    Inventors: Casu Banito, Torri Giangiacomo, Naggi Anna Maria, Giannini Giuseppe, Pisano Claudio, Penco Sergio